Bendalis GmbH

Bendalis GmbH is a specialized pharmaceutical company focused on the development (in collaboration with third parties) and marketing of high-barrier generic drugs and patented oncology medications in the German and international markets. As of the end of 2014, Bendalis GmbH had total assets of 2.8 million euros, sales revenue of 5.4 million euros, and a net profit of 200,000 euros.